The National Institute on Drug Abuse is offering a grant to develop Virtual Reality tools that enhance evidence-based treatment for Substance Use Disorders (SUD). The grant aims to create VR technologies supporting SUD treatment, chronic pain management, and innovative research tools for SUD and mental health disorders. Phase I focuses on device feasibility and validation, while Phase II evaluates VR platform efficacy in a larger sample. Results will aid in FDA medical device clearance. Applications for this grant must be submitted by March 20, 2019, 12:00 AM EDT.
Opportunity ID: 311961
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-19-032 |
| Funding Opportunity Title: | Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 11, 2019 |
| Last Updated Date: | Jan 11, 2019 |
| Original Closing Date for Applications: | Mar 20, 2019 |
| Current Closing Date for Applications: | Mar 20, 2019 |
| Archive Date: | Apr 25, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See the funding announcement for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to develop and evaluate Virtual Reality (VR) enhanced technologies that will support SUD treatment and recovery, provide treatment alternatives for chronic pain, or serve as next generation Clinical Research Tools which leverage data from the VR experience and identify digital markers that model SUD and comorbid mental illness disorders. The objective of Phase I (R43) is to establish the feasibility and/or validation of the device, and Phase 2 is designed to test the efficacy of the VR platform in a larger sample. For VR digital therapeutics, data generated from these studies are to be used to support a 510k submission to seek clearance as an FDA medical device. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-032.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00247427 | Feb 20, 2019 | Mar 20, 2019 | View |
Package 1
Mandatory forms
311961 RR_SF424_2_0-2.0.pdf
311961 PHS398_CoverPageSupplement_4_0-4.0.pdf
311961 RR_OtherProjectInfo_1_4-1.4.pdf
311961 PerformanceSite_2_0-2.0.pdf
311961 RR_KeyPersonExpanded_2_0-2.0.pdf
311961 RR_Budget_1_4-1.4.pdf
311961 RR_SubawardBudget30_1_4-1.4.pdf
311961 PHS398_ResearchPlan_4_0-4.0.pdf
311961 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
311961 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
